Ginkgo Bioworks Holdings (DNA) Inventory Average (2021 - 2023)
Ginkgo Bioworks Holdings' (DNA) quarterly Inventory Average came in at $230500.0 in Q3 2023, down 96.7% YoY from $7.0 million in Q3 2022, and down 84.1% on a QoQ basis from $1.4 million in Q2 2023.
Ginkgo Bioworks Holdings (DNA) Inventory Average (2021 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has 3 years of Inventory Average data on file, last reported at $230500.0 in Q3 2023.
- Quarterly Inventory Average fell 96.7% year-over-year to $230500.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $230500.0 (down 96.7% YoY) and the FY2022 annual result came in at $3.9 million, up 26.7% from the prior year.
- Inventory Average slipped to $230500.0 in Q3 2023, from $1.4 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $8.4 million in Q2 2022 to a low of $230500.0 in Q3 2023.
- A 3-year average of $4.4 million and a median of $4.3 million in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average soared 49.56% — and 2023, when it slumped 96.7%.
- Tracing DNA's Inventory Average over 3 years: stood at $3.4 million in 2021, then jumped by 49.56% to $5.1 million in 2022, then tumbled by 95.49% to $230500.0 in 2023.
- The last three Inventory Average figures came in at $230500.0 (Q3 2023), $1.4 million (Q2 2023), and $3.4 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Ginkgo Bioworks Holdings | 432.60 Mn | 348.06 Mn | 18.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 230,500.00 |
| Jun 30, 2023 | 1.45 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 5.11 Mn |
| Sep 30, 2022 | 6.98 Mn |
| Jun 30, 2022 | 8.40 Mn |
| Mar 31, 2022 | 6.03 Mn |
| Dec 31, 2021 | 3.42 Mn |